Dr. Goldberg on Options After Developing Resistance to Osimertinib for NSCLC OncLive 1:16 6 years ago 1 499 Далее Скачать
Dr. Goldberg on Sequencing Following Treatment With Osimertinib in NSCLC OncLive 2:00 6 years ago 235 Далее Скачать
Dr. Goldberg Discusses Resistance to EGFR TKI Therapy in NSCLC OncLive 2:02 6 years ago 138 Далее Скачать
Osimertinib for EGFR T790M Resistance Mutations in NSCLC OncLive 3:59 7 years ago 1 210 Далее Скачать
Dr. Yang on Resistance Mechanisms from Osimertinib in NSCLC OncLive 1:33 6 years ago 554 Далее Скачать
Sarah B. Goldberg Discusses New Immunotherapy Options for Patients With Lung Cancer OncLive 1:09 8 years ago 272 Далее Скачать
Acquired Resistance to Osimertinib in EGFR+ NSCLC - 2022 Program: Targeted Therapies Forum - English GRACE - Global Resource for Advancing Cancer Education 2:30 2 years ago 636 Далее Скачать
2020 TTF EGFR Breakout PIOTROWSKA Part 1 - Current Options Upon Acquired Resistance to Osimertinib GRACE - Global Resource for Advancing Cancer Education 11:23 3 years ago 169 Далее Скачать
Post-Osimertinib Treatment Options for EGFR+ NSCLC - Targeted Therapies in Lung Cancer 2023 GRACE - Global Resource for Advancing Cancer Education 2:43 1 year ago 384 Далее Скачать
Dr. Oxnard on Detecting Resistance Mechanisms After Treatment With Osimertinib OncLive 1:31 7 years ago 773 Далее Скачать
Dr. Padda on Overcoming Resistance to Osimertinib in EGFR+ NSCLC OncLive 1:43 5 years ago 3 327 Далее Скачать
